Ratings Harte Hanks, Inc.

Equities

HHS

US4161962026

Market Closed - Nasdaq 16:30:00 2024-05-03 EDT 5-day change 1st Jan Change
7.11 USD +0.74% Intraday chart for Harte Hanks, Inc. -0.56% +4.71%

Strengths

  • With a P/E ratio at 14.08 for the current year and 6.77 for next year, earnings multiples are highly attractive compared with competitors.
  • The stock, which is currently worth 2024 to 0.16 times its sales, is clearly overvalued in comparison with peers.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

Ratings chart - Surperformance

Sector: Advertising & Marketing

1st Jan change Capi. Investor Rating ESG Refinitiv
+4.71% 51.52M -
-15.12% 1.86B
B-
-17.50% 561M - -
+11.87% 390M - -
-28.16% 383M - -
+28.71% 184M
C
+18.69% 121M - -
+6.82% 97.36M - -
-56.54% 96.35M - -
+66.04% 93.53M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. HHS Stock
  4. Ratings Harte Hanks, Inc.